Security key
10806X102
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 193,809,015
- Total 13F shares
- 149,815,028
- Share change
- -2,496,818
- Total reported value
- $2,576,329,186
- Put/Call ratio
- 75%
- Price per share
- $17.20
- Number of holders
- 196
- Value change
- -$39,862,601
- Number of buys
- 97
- Number of sells
- 97
Report period
Q2 2023
Institutions
196
Top holders
10
BBIO full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10806X102
Recent filing periods:
Top shareholders of BBIO - BridgeBio Pharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
16%
|
31,060,971
|
$514,990,899 | — | 31 Mar 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
14%
|
26,620,991
|
$441,376,031 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
12,063,256
|
$200,008,785 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.7%
|
9,117,781
|
$151,172,809 | — | 31 Mar 2023 | |
| Aisling Capital Management LP |
13F
|
Company |
3.1%
|
6,068,125
|
$100,609,513 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
5,143,013
|
$85,271,156 | — | 31 Mar 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.4%
|
4,557,414
|
$75,562,000 | — | 31 Mar 2023 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.1%
|
3,978,410
|
$65,962,038 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
1.8%
|
3,512,759
|
$58,241,544 | — | 31 Mar 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
1.4%
|
2,704,374
|
$44,838,521 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
2,253,158
|
$37,357,371 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
2,232,021
|
$37,006,908 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.1%
|
2,104,234
|
$34,888,206 | — | 31 Mar 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.98%
|
1,907,033
|
$31,618,607 | — | 31 Mar 2023 | |
| SC US (TTGP), LTD. |
13F
|
Company |
0.96%
|
1,860,364
|
$30,844,835 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.8%
|
1,547,045
|
$25,650,006 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.74%
|
1,442,432
|
$23,915,523 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.7%
|
1,365,057
|
$22,632,646 | — | 31 Mar 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.69%
|
1,338,160
|
$22,186,693 | — | 31 Mar 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.6%
|
1,171,650
|
$19,425,957 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.56%
|
1,084,595
|
$17,982,585 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.56%
|
1,080,259
|
$17,910,694 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
1,042,486
|
$17,284,418 | — | 31 Mar 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.52%
|
1,000,000
|
$16,580,000 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
975,231
|
$16,169,330 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
957,357
|
$15,872,979 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
941,176
|
$15,604,698 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
924,822
|
$15,333,549 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.47%
|
914,791
|
$15,167,234 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.4%
|
779,540
|
$12,924,773 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.39%
|
763,746
|
$12,663,000 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.39%
|
762,306
|
$12,639,033 | — | 31 Mar 2023 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.38%
|
739,992
|
$12,269,067 | — | 31 Mar 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.38%
|
732,828
|
$12,150,289 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.36%
|
704,486
|
$11,680,376 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.35%
|
670,879
|
$11,123,174 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.31%
|
594,686
|
$9,859,894 | — | 31 Mar 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.29%
|
561,983
|
$9,317,678 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.27%
|
525,308
|
$8,709,606 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
521,077
|
$8,639,000 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.26%
|
500,000
|
$8,290,000 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
468,796
|
$7,772,638 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
388,086
|
$6,434,465 | — | 31 Mar 2023 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
372,588
|
$6,177,509 | — | 31 Mar 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.19%
|
364,000
|
$6,035,120 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.18%
|
343,785
|
$5,699,955 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
341,280
|
$5,658,422 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
336,368
|
$5,577,000 | — | 31 Mar 2023 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.17%
|
331,283
|
$5,492,672 | — | 31 Mar 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.17%
|
320,000
|
$5,305,600 | — | 31 Mar 2023 |
Institutional Holders of BridgeBio Pharma, Inc. - Common Stock (BBIO) as of Q2 2023
As of 30 Jun 2023,
BridgeBio Pharma, Inc. - Common Stock (BBIO) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
149,815,028 shares.
The largest 10 holders included
Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Aisling Capital Management LP, Laurion Capital Management LP, Cormorant Asset Management, LP, HHLR ADVISORS, LTD., and PICTET ASSET MANAGEMENT SA.
This page lists
196
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
210
Q2 2023 holders
196
Holder diff
-14
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.